Literature DB >> 15101418

Analysis of 'driver' and 'passenger' CD8+ T-cell responses against variable viruses.

Andreas Zafiropoulos1, Eleanor Barnes, Clive Piggott, Paul Klenerman.   

Abstract

Variable viruses, such as human immunodeficiency virus (HIV) and hepatitis C virus (HCV), persist despite host immune responses directed against them. Numerous lines of evidence have suggested that antiviral CD8+ T-cell responses are key among these immune responses, but these vary widely in their ability to contain virus. We propose that only a proportion of responses may exert significant antiviral pressure ('driver' responses), leading to control over viral replication (protection) and/or, ultimately, selection of escape mutants. Another set of responses may exert only weak pressure on the virus ('passenger' responses): these neither protect nor select. To examine this we have analysed (using established databases of HIV and HCV sequences and cytotoxic T-lymphocyte (CTL) epitopes, and published experimental datasets) two important features--predicted binding of the epitope to major histocompatibility complex molecule and observed variability of the epitope--that might distinguish such responses. We find that a high predicted binding estimate could only explain a limited set of 'driver' responses associated with protection or selection. There is statistical evidence that readily defined (and non-protective) CTL responses target regions associated with lower levels of viral variability. Taken together, this suggests that a large number of well-documented responses may represent 'passengers' and we propose a mechanism that might explain their presence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15101418      PMCID: PMC1809984          DOI: 10.1098/rsbl.2003.0088

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  11 in total

Review 1.  HIV: current opinion in escapology.

Authors:  Paul Klenerman; Ying Wu; Rodney Phillips
Journal:  Curr Opin Microbiol       Date:  2002-08       Impact factor: 7.934

2.  Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS.

Authors:  P J Goulder; R E Phillips; R A Colbert; S McAdam; G Ogg; M A Nowak; P Giangrande; G Luzzi; B Morgan; A Edwards; A J McMichael; S Rowland-Jones
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

Review 3.  Cellular immune responses against hepatitis C virus: the evidence base 2002.

Authors:  S Ward; G Lauer; R Isba; B Walker; P Klenerman
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

Review 4.  Memory CD8+ T cells in HIV infection.

Authors:  A J McMichael; G Ogg; J Wilson; M Callan; S Hambleton; V Appay; T Kelleher; S Rowland-Jones
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

5.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

Authors:  K L Collins; B K Chen; S A Kalams; B D Walker; D Baltimore
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

6.  Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.

Authors:  Corey B Moore; Mina John; Ian R James; Frank T Christiansen; Campbell S Witt; Simon A Mallal
Journal:  Science       Date:  2002-05-24       Impact factor: 47.728

7.  Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.

Authors:  Karina Yusim; Can Kesmir; Brian Gaschen; Marylyn M Addo; Marcus Altfeld; Søren Brunak; Alexandre Chigaev; Vincent Detours; Bette T Korber
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 8.  The influence of HLA genotype on AIDS.

Authors:  Mary Carrington; Stephen J O'Brien
Journal:  Annu Rev Med       Date:  2001-12-03       Impact factor: 13.739

Review 9.  HCV immunology--death and the maiden T cell.

Authors:  C Willberg; E Barnes; P Klenerman
Journal:  Cell Death Differ       Date:  2003-01       Impact factor: 15.828

10.  Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.

Authors:  F R Carbone; M J Bevan
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

View more
  7 in total

Review 1.  HIV-specific CD8⁺ T cells and HIV eradication.

Authors:  R Brad Jones; Bruce D Walker
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

2.  Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection.

Authors:  Thillagavathie Pillay; Hua-Tang Zhang; Jan W Drijfhout; Nicola Robinson; Helen Brown; Munira Khan; Jagadesa Moodley; Miriam Adhikari; Katja Pfafferott; Margaret E Feeney; Anne St John; Edward C Holmes; Hoosen M Coovadia; Paul Klenerman; Philip J R Goulder; Rodney E Phillips
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.

Authors:  Yukie Tanaka; Hideki Nakasone; Rie Yamazaki; Hidenori Wada; Yuko Ishihara; Koji Kawamura; Kana Sakamoto; Masahiro Ashizawa; Tomohito Machishima; Miki Sato; Kiriko Terasako; Shun-ichi Kimura; Misato Kikuchi; Shinya Okuda; Shinichi Kako; Junya Kanda; Aki Tanihara; Junji Nishida; Yoshinobu Kanda
Journal:  J Clin Immunol       Date:  2012-07-05       Impact factor: 8.317

4.  How does HTLV-I persist despite a strong cell-mediated immune response?

Authors:  Becca Asquith; Charles R M Bangham
Journal:  Trends Immunol       Date:  2007-11-26       Impact factor: 16.687

5.  Application of magnetic field hyperthermia and superparamagnetic iron oxide nanoparticles to HIV-1-specific T-cell cytotoxicity.

Authors:  James P Williams; Paul Southern; Anya Lissina; Helen C Christian; Andrew K Sewell; Rodney Phillips; Quentin Pankhurst; John Frater
Journal:  Int J Nanomedicine       Date:  2013-07-23

Review 6.  T cell sensitivity and the outcome of viral infection.

Authors:  L J Walker; A K Sewell; P Klenerman
Journal:  Clin Exp Immunol       Date:  2009-12-01       Impact factor: 4.330

7.  The specificity and polymorphism of the MHC class I prevents the global adaptation of HIV-1 to the monomorphic proteasome and TAP.

Authors:  Boris V Schmid; Boris Schmid; Can Keşmir; Rob J de Boer
Journal:  PLoS One       Date:  2008-10-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.